The Lewis B. and Dorothy Cullman
Chemoprotection Center
at Johns Hopkins University School of Medicine

  • Home
  • News
  • About Us ▾
    • Scientific Strategy
    • Supporters
    • Videos & Other Media
  • Accomplishments
  • Research ▾
    • Current Experimental Projects
    • Preventive Clinical Studies ▸
      • CCC-Involved Studies
      • Other Studies (Non-CCC)
    • Scientific Publications
  • FAQ
  • Staff
  • Contact Us

Chemoprotection Center News | April 2020

Posted April 20, 2020

Our Latest News | April 2020

Our recent study identified biomarkers for response to sulforaphane treatment in boys with autism.

Autism spectrum disorder, or ASD, is a neurodevelopment disorder characterized by impaired social interaction and communication, as well as restrictive,

… Read More

Chemoprotection News | September 2019

Posted September 9, 2019

Our Latest News

The CCC and Dr. Jed Fahey were featured in the media again this summer. Kate Krader of Bloomberg’s Businessweek interviewed Dr. Fahey for this entertaining story about how a growing number of chefs are incorporating moringa into

… Read More

Chemoprotection News

Posted May 22, 2019

Our Latest News

Korean documentarians Hyun Sik Noh and Ryan Lee have produced a documentary about moringa for Korean television. Excerpts of the video (with English subtitles) feature the Cullman Center’s Dr. Jed Fahey and its phytochemistry lab and highlight 

… Read More

Chemoprotection News

Posted March 4, 2019

Our Latest News 

Moringa and the Cullman Center’s Dr. Jed Fahey are featured in this video from ATTN*, which has had more than 3 million views! Click on the image below to view.


*ATTN: is a relatively new media company

… Read More

December 2018 Newsletter

Posted December 7, 2018

Our Latest News

Autism Research. In 2014 we collaborated with Dr. Andrew Zimmerman (pictured, right) and his team at Harvard University and published the results of a clinical trial with 44 boys and young men with autism spectrum disorder. There

… Read More

September Newsletter

Posted September 1, 2018

Our Latest News

Welcome to our Cullman Chemoprotection Center family.  We hope to use this newsletter as a way to reach out to the growing network of people who are interested in our sort of research.  Whereas most scientist-to-scientist communication
… Read More

Recent Posts

  • Profiles in Chemoprotection, Part I
  • Our recent autism biomarkers paper selected for Open Access
  • Sulforaphane and Epilepsy
  • New Study from Korea: Sulforaphane Has Positive Effects in a Mouse Model of Alzheimer’s Disease
  • New study indicates ability of oral sulforaphane to boost antioxidant response in the human brain
  • Autism, Broccoli, & Urine!
  • Exciting News for the Spring
  • New Paper on Long Term Use of Broccoli Sprout Supplements and Autism Symptoms
  • Dr. Fahey talks about Moringa oleifera in a new podcast
  • More Public Interest in Sulforaphane
  • Dr. Fahey Talks about Sulforaphane on a New Podcast
  • New Reata Scholar Joins the Chemoprotection Center
  • The Bioavailability of Nutritional Supplements Rich in Sulforaphane
  • Release of new Webinar and Podcast on Isothiocyanates, Nrf2, Moringa & Sulforaphane Supplementation
  • An update on links between obesity and cancer
  • The Cullman Center Weighs in on Moringa Leaf Protein
  • Is the vitamin and phytochemical content of fruit declining?
  • Moringa health and economic benefits
  • A Matter of Taste
  • . . . wheatgrass is not a superfood
  • New Coffee Claims Health Benefits of Broccoli
  • Will Progeria respond to phytochemicals like sulforaphane?
  • Autism Study Frequently Asked Questions
  • A Promising New Treatment for Autism Syndrome Disorder (ASD)
  • Press Coverage on China Study

Categories

  • Autism
  • Broccoli
  • Cancer
  • Category WW
  • Chronic Disease
  • Clinical Studies
  • Fruits and Vegetables
  • Inflammation
  • Moringa
  • Nutrition
  • Phytochemistry
  • Profiles in Chemoprotection
  • Schizophrenia

Click here to make a donation to the Brassica Foundation in support of this exciting science

Contact

Dr. Jed Fahey, Director
Cullman Chemoprotection Center
Johns Hopkins University School of Medicine

jfahey@jhmi.edu

Connect with the Chemoprotection Center

facebook twitter

Sign-up for our Newsletter

The Cullman Chemprotection Center receives funding from private donations

  • Home
  • About Us
  • Scientific Strategy
  • Supporters
  • Videos & Other Media
  • Accomplishments
  • Current Experimental Projects
  • Preventive Clinical Studies
  • FAQ
  • Glossary
  • Newsletters
  • Staff
  • Contact
  • Chemoprotection Center News

© 2025 The Lewis B. and Dorothy Cullman Chemoprotection Center at Johns Hopkins School of Medicine. All rights reserved.

website design & development by undertow creative